Venkata Suryanarayana Murthy Bhavaraju
Researcher
Graduate Student Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Venkata Suryanarayana Murthy Bhavaraju's research focuses on the application of CRISPR-based technologies for the diagnosis and treatment of COVID-19. He has investigated advancements in these areas, contributing to the development of novel solutions for the ongoing pandemic. His work also extends to understanding the complex etiology of Attention-Deficit/Hyperactivity Disorder (ADHD), exploring current challenges and future directions for its treatment. Bhavaraju has published one paper, which has garnered 12 citations, and holds an h-index of 1. He collaborates with researchers Shilpi Agrawal, Shivakumar Sonnaila, and Roaa Hadi at the University of Arkansas at Fayetteville.
Metrics
- h-index: 1
- Publications: 1
- Citations: 12
Selected Publications
-
Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment (2025)
-
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics (2024)
Collaboration Network
Top Collaborators
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment
Similar Researchers
Based on overlapping research topics